<DOC>
	<DOCNO>NCT02920359</DOCNO>
	<brief_summary>The study consist generation biological sample ( urine ) positive leuprorelin acetate dope control new develop method , establish analytical parameter reveal administration Leuprorelin acetate healthy volunteer method .</brief_summary>
	<brief_title>Generation Positive Biological Samples Leuprolide Acetate Doping Control</brief_title>
	<detailed_description />
	<mesh_term>Leuprolide</mesh_term>
	<criteria>1 . Healthy male volunteer age 18 45 year . 2 . Understanding accept study procedure sign informed consent form . 3 . A health profile devoid organic physiological disorder . 4 . The ECG general blood urine laboratory test perform study within normal range . Minor occasional change normal range accept , investigator 's opinion , consider current state art , clinically significant , lifethreatening subject interfere product assessment . These change nonrelevance justify write specifically . 5 . Body mass index ( BMI=weigh/height2 ) range 19 25 Kg/m2 weight 50 100 kg . BMI 25 27 kg/m2 include principal investigator criterion . 1 . Non compliance inclusion criterion . 2 . History allergy , idiosyncrasy , hypersensitivity adverse reaction active substance , similar nonapeptides excipients . 3 . History allergy adverse reaction medication . 4 . Subjects drug involve study counter indicate . 5 . History clinical evidence gastrointestinal , liver , renal disorder may lead suspect disorder drug absorption , distribution , metabolism excretion , suggest gastrointestinal irritation due drug . 6 . History clinical evidence alcoholism , drug abuse , regular use psychoactive drug . 7 . Have volunteer another study drug last 3 month prior start study . 8 . Have take part study blood donation last 2 month prior start study . 9 . Having suffer organic disease major surgery six month prior start study . 10 . A prior history presence significant cardiovascular , neurological , haematological , psychiatric , hepatic , gastrointestinal , pulmonary , endocrine , immunologic renal disease , investigator 's opinion , consider current state art , clinically significant , lifethreatening subject could interfere product assessment . Especially seizures history epilepsy . 11 . Regular use drug month prior study session , except vitamin , herbal remedy dietary supplement , investigator 's opinion , consider current state art , clinically significant , lifethreatening subject interfere product assessment . The treatment single limited dos symptomatic medicinal product week prior study session reason exclusion calculate cleared completely day experimental session . 12 . Smokers 20 cigarette per day last 3 month prior start study . 13 . Taking 40 g alcohol per day . 14 . Drinking 5 cup per day coffee , tea , coke , stimulant equivalent , drink contain xanthine , 3 month prior start study . 15 . Subjects unable understand nature , consequence study procedure request follow . 16 . Subjects positive serology hepatitis B , C HIV . 17 . Subjects anormal value testosterone prostatespecific antigen accord age normal value .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>